A recent study showed that TREM2 and TREML2 could strictly regulate microglial proliferation, whose dysfunctions may contribute to AD pathogenesis via impairing brain innate immunity (Zheng et al., 2016). This evidence concerns the gene TREML2 and Alzheimer disease.